Eidos Therapeutics, Inc. Operating Income 2018-2020 | EIDX
Eidos Therapeutics, Inc. operating income from 2018 to 2020. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Eidos Therapeutics, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2019 | $-40 |
| 2018 | $-38 |
| 2017 | $-12 |
| 2016 | $-2 |
| Eidos Therapeutics, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2020-09-30 | $-29 |
| 2020-06-30 | $-28 |
| 2020-03-31 | $-23 |
| 2019-12-31 | $-19 |
| 2019-09-30 | $6 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-13 |
| 2018-12-31 | $-11 |
| 2018-09-30 | $-11 |
| 2018-06-30 | $-8 |
| 2018-03-31 | $-8 |
| 2017-12-31 | $-5 |
| 2017-09-30 | $-3 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-2 |
